There are several biomarkers associated with autoimmune diseases (such as copeptin with multiple sclerosis, NGAL, and systemic lupus erythematosus), therefore we have excluded patients with autoimmune disorders from our study [29,30]. This evidence concerns the gene LCN2 and multiple sclerosis.